$17.49+0.20 (+1.16%)
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
Sotera Health Company in the Healthcare sector is trading at $17.49 with a market capitalization of $5.0B. Wall Street consensus targets $20.44 (9 analysts), implying a +16.9% move over the next 12 months. The stock is currently 12% below its 52-week high of $19.85, remaining 6.5% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $280.05M↓ | $303.44M↓ | $311.31M↑ | $294.34M↑ | $254.52M |
| Gross Profit | $147.07M↓ | $165.92M↓ | $177.56M↑ | $166.62M↑ | $135.43M |
| Operating Income | $75.83M↓ | $105.38M↓ | $111.18M↑ | $88.43M↑ | $57.04M |
| Net Income | $26.59M↓ | $34.85M↓ | $48.40M↑ | $7.96M↑ | -$13.26M |
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and N...
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Sotera Health Company currently trades at $17.92 per share and has shown little upside over the past six months, posting a small loss of 4.7%. The stock also fell short of the S&P 500’s 8% gain during that period.
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
Is SHC a good stock to buy? We came across a bullish thesis on Sotera Health Company on Valueinvestorsclub.com by AZA0601. In this article, we will summarize the bulls’ thesis on SHC. Sotera Health Company’s share was trading at $17.10 as of June 25th. SHC’s trailing and forward P/E were 41.71 and 17.27 respectively according to Yahoo […]
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destocking have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 7.7% has lagged the S&P 500’s 9.3% climb.